Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amitiza for Capsule Endoscopy Preparation
NCT00746395Phase 4
Key facts
- Status
- Completed
- Start
- Apr 2008
- Primary completion
- Sep 2008
- Countries
- 1
- Sponsor
- University of South Alabama
- Modality
- Orthosteric Ligands
- Drugs
- cobiprostone
- Conditions
- inflammatory bowel disease (IBD)
01
Overview
Phase 4, randomised, double-blind trial of cobiprostone in inflammatory bowel disease (IBD), sponsored by University of South Alabama. Primary endpoint: Complete Small Bowel Transit at 8 hours. Started Apr 2008; status: completed.
02
Design
- Study design
- RandomizedDouble-blind
03
Who it enrols
Healthy volunteers with no history of gastrointestinal disorders, surgery, or significant organ insufficiency.
04
Endpoints
Primary
Complete Small Bowel Transit
Secondary
Small Bowel Transit
Beyond the preview
Go deeper on NCT00746395.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00746395.